Divi’s Laboratories Q4 results: PAT surges 26% YoY, revenue up 12%

May 17, 2025

Divi’s Laboratories announced a robust financial performance for the March quarter of FY25, with a 25.6% YoY surge in standalone net profit, reaching Rs 667 crore. Revenue from operations also climbed by 12.26% to Rs 2,536 crore. The company’s board declared a dividend of Rs 30 per share and its Unit III greenfield project has commenced commercial operations.

More To Explore

Tata Motors CV arm listing date announced. Check details

Tata Motors’ commercial vehicle arm (TMCV) will debut on exchanges on November 12, completing the automaker’s demerger into two listed entities—one for CVs and another

November 10, 2025

CleanMax gets Sebi nod for Rs 5,200 crore IPO, eyes debt reduction and growth push

Clean Max Enviro Energy Solutions, India’s top C&I renewable energy provider, received Sebi approval for its ₹5,200 crore IPO, comprising ₹1,500 crore fresh issue and

November 10, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003